After topical treatment with a tumor initiator and repeated promoter applications, these mice developed significantly fewer squamous cell tumors compared with WT mice [17], suggesting an important role of VEGF-C/D in shaping the inflammatory tumor microenvironment that regulates early tumor progression. Here, VEGFC is linked to neoplasm.